Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study on Safety of 60 Days Administration of Triticum Monococcum in Patients With Celiac Disease on Remission in Gluten Free Diet

NCT02220166 is registered in ClinicalTrials.gov with Università degli Studi di Brescia as lead sponsor.

NCT NCT02220166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02220166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study on Safety of 60 Days Administration of Triticum Monococcum in Patients With Celiac Disease on Remission in Gluten Free Diet
Lead sponsor
Università degli Studi di Brescia
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2010
Completion date
August 31, 2011
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease